What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes

导出原文传递

翻译打印收藏纠错

作者： Morgan,C.Ll. ^[1] ; Poole,C.D. ^[2] ; Evans,M. ^[3] ; Barnett,A.H. ^[4] ; Jenkins-Jones,S. ^[5] ; Currie,C.J.

作者单位： Department of Medicine, University Hospital of Wales, Llandough, Cardiff CF64 2XX, United Kingdom ^[1] University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom ^[2] Division of Clinical and Experimental Medicine, University of Birmingham, Heart of England National ^[3] Department of Global Epidemiology, Pharmatelligence, Cardiff MediCentre, Cardiff CF14 4UJ, United ^[4] School of Medicine, Cardiff University, Pharma Research Centre, Cardiff CF14 4UJ, United Kingdom ^[5]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The Journal of Clinical Endocrinology and Metabolism

2012年97卷12期

4605-4612页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes

The Journal of Clinical Endocrinology and Metabolism

相似文献

The Journal of Clinical Endocrinology and Metabolism

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes

The Journal of Clinical Endocrinology and Metabolism

相似文献

The Journal of Clinical Endocrinology and Metabolism

相关期刊

检索历史清除